Seastar Medical Hldg Corp (ICU) Stock Price, Quote & News

Company Profile

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due...

Industry: Biotechnology

Sector: Healthcare

Phone: 844 427 8100

Website: seastarmedical.com

Address:

3513 Brighton Boulevard, Suite 410, Denver, United States

Greenvisions May. 27 at 9:01 AM

$ICU $CANF $BVC $RTB.X reset

0 · Reply

Arogart May. 27 at 6:58 AM

$ICU Product 👍👍👍, CEO 👎👎👎! I'm already down 50k here and I'm still holding on. I must be crazy, but I believe in SCD. However, in my opinion, Schlorff is completely unsuitable to run such a company. He's an accountant, not a CEO. Slow as a snail, poor communication, and charisma as a sloth...

0 · Reply

RJLeonii May. 27 at 2:41 AM

$ICU SAVE registry is one week closer. This will change the standard of care for all pediatric hospital nephrology units! 50% reduction in mortality! Keep saving lives!

0 · Reply

Yi_YandH May. 27 at 12:49 AM

$ICU A 20% greater survival rate…..matters…..bigly! https://karger.com/bpu/article-pdf/55/2/107/4456545/000549111.pdf

0 · Reply

local42r May. 26 at 10:19 PM

$ICU Performing like a sick puppy 🐶 WTF

0 · Reply

Yi_YandH May. 26 at 8:28 PM

$ICU

0 · Reply

Yi_YandH May. 26 at 8:26 PM

Hit reset $ICU! Ready? Set? Are we going? Mgmt has gone almost totally silent. What gives? Speak when spoken to? What goes around comes around? Silence is Golden Grail? Recent LinkedIn post by some outfit! ———-No mention whatsoever about the life saving, kidney bettering, dialysis preventing watchamacallit that has been available for purchase by hospitals nationwide for almost 2 years now. America the beautiful? America the slow as molasses, allowing and/or forcing physicians to violate their Hippocratic Oath over, and over, and over again with every child they treat, every human under the age of 22 that they treat and every adult that they treat while not screaming for an EUA from the FDA. THE SELECTIVE CYTOPHERETIC DEVICE - intercepts the need for dialysis. A happy kidney matters! Two happy kidneys matter just as much as one!

0 · Reply

MasheredTrader May. 26 at 8:02 PM

$ICU well, on a good note, most of my averages are in the $4’s now. It wasn’t easy to do ! Only up from here!

1 · Reply

alien91 May. 26 at 7:29 PM

$ICU lol, back to $2? ._. i guess I can buy a lot more than I thought^^

0 · Reply

BottomUp00 May. 26 at 6:54 PM

$ICU Refilled below 3.50. Still averaging down.

0 · Reply

SeaStar Medical price target raised to $8 from $6 at Maxim

May 13, 2026, 4:30 PM EDT - 13 days ago

SeaStar Medical Holding Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 13 days ago

SeaStar Medical Holding Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 13 days ago

SeaStar Medical Holding Quarterly report: Q1 2026

May 13, 2026, 4:05 PM EDT - 13 days ago

SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates

May 7, 2026, 8:00 AM EDT - 19 days ago

SeaStar Medical Holding Registration statement: Registration filing

May 6, 2026, 8:20 AM EDT - 20 days ago

SeaStar Medical to Report First Quarter Financial Results on May 13, 2026

Apr 29, 2026, 8:00 AM EDT - 27 days ago

SeaStar Medical Holding Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 4 weeks ago

SeaStar Medical Holding Registration statement: Registration filing

2026-03-30T13:27:26.000Z - 2 months ago

SeaStar Medical showcases new data from SAVE Registry

Mar 30, 2026, 8:20 AM EDT - 2 months ago

SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

Mar 25, 2026, 4:30 PM EDT - 2 months ago

SeaStar Medical Holding Earnings Call Transcript: Q4 2025

Mar 25, 2026, 4:30 PM EDT - 2 months ago

SeaStar Medical Holding Annual report: Q4 2025

Mar 25, 2026, 4:30 PM EDT - 2 months ago

SeaStar Medical Holding Earnings release: Q4 2025

Mar 25, 2026, 4:05 PM EDT - 2 months ago

SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Mar 18, 2026, 4:05 PM EDT - 2 months ago

SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

Mar 11, 2026, 12:00 PM EDT - 2 months ago

SeaStar Medical Holding Transcript: Life Sciences Virtual Investor Forum

Mar 9, 2026, 8:35 AM EDT - 2 months ago

SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th

2026-03-05T13:36:45.000Z - 2 months ago

SeaStar Medical completes FDA enrollment requirement for SAVE Registry

Mar 5, 2026, 8:20 AM EST - 2 months ago

SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI

2026-02-12T14:06:17.000Z - 3 months ago

SeaStar Medical price target lowered to $6 from $10 at Maxim

2026-02-09T13:25:53.000Z - 3 months ago

SeaStar Medical reports ‘strong’ survival data in Quelimmune study

Feb 9, 2026, 8:20 AM EST - 3 months ago

SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)

Jan 29, 2026, 8:25 AM EST - 4 months ago

SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference

Jan 13, 2026, 6:00 PM EST - 4 months ago

SeaStar Medical Holding Transcript: Biotech Showcase 2026

Jan 9, 2026, 7:00 AM EST - 4 months ago

SeaStar Medical Holding Slides: Investor presentation

2026-01-07T13:21:08.000Z - 4 months ago

SeaStar Medical announces 2026 milestones

Jan 7, 2026, 8:13 AM EST - 4 months ago

SeaStar Medical Announces 2026 Milestones

Jan 6, 2026, 8:53 AM EST - 5 months ago

SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference

2026-01-03T00:50:17.000Z - 5 months ago

SeaStar Medical Holding Corp trading halted, news pending

2025-12-23T21:30:17.000Z - 5 months ago

SeaStar Medical announces 1-for-10 reverse stock split

Dec 23, 2025, 4:25 PM EST - 5 months ago

SeaStar Medical Announces 1-for-10 Reverse Split

2025-12-02T13:30:31.000Z - 6 months ago

SeaStar reports approval for reduction in mandatory enrollment for SAVE registry

Dec 2, 2025, 8:27 AM EST - 6 months ago

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

Nov 20, 2025, 9:52 AM EST - 6 months ago

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

2025-11-17T13:50:19.000Z - 6 months ago

SeaStar Medical appoints Michael Messinger as CFO

Nov 17, 2025, 8:43 AM EST - 6 months ago

SeaStar Medical Announces Appointment of Michael Messinger as CFO

Nov 14, 2025, 7:00 AM EST - 6 months ago

SeaStar Medical Holding Proxy statement: Proxy Filing

Nov 13, 2025, 4:30 PM EST - 6 months ago

SeaStar Medical Holding Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 6 months ago

SeaStar Medical Holding Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 6 months ago

SeaStar Medical Holding Earnings release: Q3 2025

Nov 13, 2025, 4:05 PM EST - 6 months ago

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 5, 2025, 10:03 AM EST - 7 months ago

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

Nov 4, 2025, 7:00 AM EST - 7 months ago

SeaStar Medical Holding Proxy statement: Proxy Filing

2025-09-29T13:00:23.000Z - 8 months ago

SeaStar Medical announces preliminary results from SAVE Surveillance Registry

Sep 29, 2025, 8:36 AM EDT - 8 months ago

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

2025-09-25T13:24:14.000Z - 8 months ago

Why Is SeaStar Medical Stock (ICU) Down 45% Today?

2025-09-24T20:40:35.000Z - 8 months ago

Review board recommends SeaStar Medical continue with NEUTRALIZE-AKI trial

Sep 24, 2025, 4:22 PM EDT - 8 months ago

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

Sep 23, 2025, 8:23 AM EDT - 8 months ago

SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children

Sep 5, 2025, 7:00 AM EDT - 9 months ago

SeaStar Medical Holding Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 6:13 PM EDT - 9 months ago

SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference

2025-09-02T12:45:53.000Z - 9 months ago

SeaStar Medical announces newly published QUELIMMUNE therapy

Sep 2, 2025, 8:22 AM EDT - 9 months ago

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

Aug 13, 2025, 4:30 PM EDT - 10 months ago

SeaStar Medical Holding Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 10 months ago

SeaStar Medical Holding Quarterly report: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 10 months ago

SeaStar Medical Holding Earnings release: Q2 2025

Aug 13, 2025, 4:05 PM EDT - 10 months ago

SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates

2025-08-08T21:10:33.000Z - 10 months ago

SeaStar Medical files to sell 10.92M shares of common stock for holders

Aug 8, 2025, 8:00 AM EDT - 10 months ago

SeaStar Medical Holding Registration statement: Registration Filing

Aug 7, 2025, 10:00 AM EDT - 10 months ago

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

2025-08-06T12:42:53.000Z - 10 months ago

SeaStar Medical reaches new enrollment milestone in NEUTRALIZE-AKI trial

Aug 6, 2025, 8:33 AM EDT - 10 months ago

SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)

2025-07-31T19:10:42.000Z - 10 months ago

SeaStar Medical announces $4.4M registered direct offering priced at-the-market

Jul 31, 2025, 3:01 PM EDT - 10 months ago

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

2025-07-22T12:26:36.000Z - 11 months ago

SeaStar Medical reports ‘positive’ results for QUELIMMUNE therapy in AKI

Jul 22, 2025, 8:20 AM EDT - 11 months ago

SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients

Jul 16, 2025, 8:45 AM EDT - 11 months ago

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

Jul 10, 2025, 3:29 PM EDT - 11 months ago

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 8, 2025, 8:05 AM EDT - 11 months ago

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

Jul 2, 2025, 4:25 PM EDT - 11 months ago

SeaStar Medical Announces Positive Nasdaq Listing Determination

Jun 25, 2025, 8:05 AM EDT - 11 months ago

SeaStar Medical Reports Update on Nasdaq Listing Status

Jun 24, 2025, 9:05 AM EDT - 1 year ago

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

Jun 20, 2025, 12:10 PM EDT - 1 year ago

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

Jun 20, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

Jun 16, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

Jun 11, 2025, 8:25 AM EDT - 1 year ago

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research

May 28, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

May 20, 2025, 7:00 AM EDT - 1 year ago

SeaStar Medical Holding Slides: Investor Presentation

May 19, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

May 14, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings Call Transcript: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Quarterly report: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings release: Q1 2025

May 14, 2025, 4:05 PM EDT - 1 year ago

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

May 13, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

May 7, 2025, 10:00 AM EDT - 1 year ago

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

May 6, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

Apr 30, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

Apr 25, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

Apr 8, 2025, 8:05 AM EDT - 1 year ago

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

Mar 27, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Annual report: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings release: Q4 2024

Mar 27, 2025, 4:05 PM EDT - 1 year ago

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Mar 24, 2025, 5:30 PM EDT - 1 year ago

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Mar 18, 2025, 8:45 AM EDT - 1 year ago

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

Mar 4, 2025, 7:00 AM EST - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

Feb 28, 2025, 7:00 AM EST - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

Feb 18, 2025, 7:00 AM EST - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

Feb 3, 2025, 4:05 PM EST - 1 year ago

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

Jan 22, 2025, 7:30 AM EST - 1 year ago

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

Jan 13, 2025, 8:30 AM EST - 1 year ago

FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

Jan 13, 2025, 7:00 AM EST - 1 year ago

SeaStar Medical Holding Slides: Investor Presentation

Jan 8, 2025, 8:30 AM EST - 1 year ago

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

Dec 23, 2024, 7:00 AM EST - 1 year ago

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

Dec 11, 2024, 6:30 AM EST - 1 year ago

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

Greenvisions May. 27 at 9:01 AM

$ICU $CANF $BVC $RTB.X reset

0 · Reply

Arogart May. 27 at 6:58 AM

0 · Reply

RJLeonii May. 27 at 2:41 AM

$ICU SAVE registry is one week closer. This will change the standard of care for all pediatric hospital nephrology units! 50% reduction in mortality! Keep saving lives!

0 · Reply

Yi_YandH May. 27 at 12:49 AM

$ICU A 20% greater survival rate…..matters…..bigly! https://karger.com/bpu/article-pdf/55/2/107/4456545/000549111.pdf

0 · Reply

local42r May. 26 at 10:19 PM

$ICU Performing like a sick puppy 🐶 WTF

0 · Reply

Yi_YandH May. 26 at 8:28 PM

$ICU

0 · Reply

Yi_YandH May. 26 at 8:26 PM

0 · Reply

MasheredTrader May. 26 at 8:02 PM

$ICU well, on a good note, most of my averages are in the $4’s now. It wasn’t easy to do ! Only up from here!

1 · Reply

alien91 May. 26 at 7:29 PM

$ICU lol, back to $2? ._. i guess I can buy a lot more than I thought^^

0 · Reply

BottomUp00 May. 26 at 6:54 PM

$ICU Refilled below 3.50. Still averaging down.

0 · Reply

brokeinvestorrr May. 26 at 6:29 PM

$ICU drop deserved as long as management sleeps on the data submission

0 · Reply

BottomUp00 May. 26 at 6:21 PM

$ICU

0 · Reply

hardgrandpa May. 26 at 6:08 PM

$ICU

0 · Reply

jmf123 May. 26 at 5:23 PM

$ICU Wow drops 5% on 60k+ shares. Reflection of what can and will happen on the upside with real volume. Waiting patiently

1 · Reply

alien91 May. 26 at 4:44 PM

$ICU will buy more with salary pouring in end of the month 😁

0 · Reply

techjerk May. 26 at 4:23 PM

$ICU

0 · Reply

Ubiquitinacious May. 26 at 4:10 PM

$ICU 4hr chart. RSI hasn’t bottomed since the low 2s…. Low float who dis

0 · Reply

Yi_YandH May. 26 at 2:53 PM

$ICU …..gives…., not…… goes…..; and these are my thoughts exactly.👍 ( I am my own identical twin here; in real life, my human identical twin and I are 82.765% alike and on the same page 79.565% of the time.) God bless the Children. SCD-PED. Call your local children’s hospital. “What’s up with your PICU AKI/SEPSIS treatment protocols these past days, weeks, months, years??”

0 · Reply

SparkyReturns May. 26 at 2:47 PM

$ICU ICU: 15M MC versus 15B+ TAM! When this takes off, why will be epic: 1 Lots of people waiting on sidelines to jump in; 2 All data show that adult SCD will be effective, just like Ped-SCD has been effective with zero adverse affects; 3 Overlap between pediatric and adult nephology doctors will mean larger immediate capture of hospital system sales once adult SCD approved; 4 Once it becomes standard of care, ICU has smaller GSA expense than typical biopharma because hospitals will have to order, and no need for a big sales force to continue sales; 5 Zero competition; 6 Fills a crucial gap in treatment options for the most serious life-threatening conditions; 7 AKI approval is just the start - likely rollout of other indications quickly after will add layers of revenue; 8 As soon as there is indication that Lincoln SEPA will be enough funding til adult approval, company will be substantially de-risked. GL longs! $SLS $MRNA $GILD $PFE

1 · Reply

BULLISH1975 May. 26 at 2:31 PM

$ICU instead of watching ICU- I sm working hard making money for done dry powder! have s great week

0 · Reply

BPler May. 26 at 1:38 PM

$ICU When do you ever see a biotech at this product level with a market cap with just 15 Mio.? Insane

0 · Reply

Edub2020 May. 26 at 1:00 PM

$ICU Any know if they could legally even say something about Ebola or sepsis with Busch at this point? I don't know the rules around this.

2 · Reply

Market Cap	14.99M
Revenue (ttm)	1.23M
Net Income (ttm)	-12.15M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-987.80%
Debt to Equity Ratio	0.00

Volume	110,200
Avg Vol	159,266
Day's Range	N/A - N/A
Shares Out	4.00M
Stochastic %K	8%
Beta	-1.04
Analysts	Strong Sell
Price Target	$10.00